In a preliminary study, we tested two uPAR inhibitors, C6, and C37, identified by the structure-based virtual screening of the National Cancer Institute (National Cancer Institute, National Health Institutes, Bethesda, MD, USA) in primary MM cells [63]. The gene discussed is PLAUR; the disease is Miyoshi myopathy.